Semax vs Selank: A Research Peptide Comparison Guide for Philippine Laboratories

For laboratory and research use only. The information below is provided strictly for educational and scientific reference. This compound is not intended for human consumption, diagnosis, or treatment.

Among the research peptides most frequently discussed in cognitive and neuropeptide literature, Semax and Selank appear together so often that laboratories sourcing them in the Philippines regularly ask how the two differ. Both originated from Russian research programs, both belong to the broad category of regulatory neuropeptides, and both are studied for their reported effects on neurochemical signaling in preclinical models. Yet their peptide sequences, parent molecules, and primary research directions are distinct. This guide compares Semax research peptide and Selank research peptide for researchers evaluating them for laboratory workflows.

Origins and Molecular Background

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH), specifically the ACTH(4-10) sequence, modified with an additional Pro-Gly-Pro terminal to improve stability against enzymatic breakdown. Selank, by contrast, is a synthetic analogue of the endogenous immunomodulatory peptide tuftsin, also stabilized with a Pro-Gly-Pro sequence. This shared stabilization strategy is one reason the two are often grouped together in literature, even though their parent molecules serve very different biological roles.

Because both are short-chain peptides, they are commonly supplied as lyophilized powder and reconstituted in the laboratory. Researchers typically prepare working solutions using bacteriostatic water and store the resulting solution under refrigeration to limit degradation.

Primary Research Focus

The published research directions for the two peptides overlap but are not identical:

• Semax has been studied primarily in the context of neuroprotection, cognitive performance markers, and modulation of brain-derived neurotrophic factor (BDNF) expression in animal and cell models.
• Selank has been examined more frequently for its reported anxiolytic-like properties and its interaction with the GABAergic and immune-signaling systems in preclinical studies.

In short, laboratory literature tends to frame Semax around cognitive and neurotrophic endpoints, while Selank is more often associated with stress-response and anti-anxiety research models. Researchers comparing the two usually select based on the specific signaling pathway their study is designed to observe.

Peptide Sequence and Stability

Semax carries the sequence Met-Glu-His-Phe-Pro-Gly-Pro, while Selank carries Thr-Lys-Pro-Arg-Pro-Gly-Pro. Both include the terminal Pro-Gly-Pro motif that slows enzymatic cleavage, which is why both are considered relatively stable among short peptides. This stability is a practical consideration in the laboratory: it affects how the reconstituted solution behaves over time and informs storage planning. Even so, neither peptide is indefinitely stable in solution, and both are typically handled with the same care as other research-grade neuropeptides.

Handling and Reconstitution Considerations

From a laboratory-workflow standpoint, Semax and Selank are handled almost identically. Common practices documented in research settings include:

• Keeping lyophilized vials refrigerated or frozen until the point of reconstitution.
• Introducing solvent slowly against the vial wall rather than directly onto the peptide pellet.
• Avoiding vigorous agitation, which can stress the peptide structure.
• Labeling each vial with concentration and reconstitution date for accurate record-keeping.

Both compounds are also available in nasal-oriented and standard research configurations, which is why researchers should confirm the exact vial format and solvent pairing before beginning a workflow. For a broader look at how solvent choice affects peptide solutions, our earlier discussion of reconstitution solvents remains a useful reference.

Choosing Between Them for a Study

There is no universally "better" peptide between the two; the appropriate choice depends entirely on the research question. A laboratory investigating neurotrophic signaling or cognitive-performance markers in a model system will generally gravitate toward Semax, while a laboratory focused on stress-response or anxiolytic-pathway research more often selects Selank. Some research programs maintain both on hand precisely because they probe adjacent but separate neurochemical systems. Researchers exploring related longevity and cellular-signaling compounds may also cross-reference peptides such as NAD+ research compound when mapping out a broader neurochemistry study.

Summary for Philippine Researchers

Semax and Selank share a common design philosophy and a common stabilizing motif, but they descend from different parent molecules and are studied along different pathways: Semax for neurotrophic and cognitive endpoints, Selank for stress and immune-signaling endpoints. For laboratories in the Philippines building out a neuropeptide research inventory, understanding this distinction helps in selecting the right compound for a given protocol. You can browse the full range of research peptides in our catalog to compare formats, concentrations, and complete sets. To explore related compounds, browse the full range of research peptides available from Regenwell PH.

Products are sold strictly for laboratory research and are not for human or animal consumption.